Mosanna Therapeutics

Pioneering a pharmaceutical nasal spray to restore natural airway control for sleep apnea.

Mosanna Therapeutics is a biotech company in Redwood City, United States, founded in 2022. It has raised $80.0M across 3 rounds, most recently an $80.0M Series A in June 2025.

Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$80.0M
Last Round
$80.0M Series AJun 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 7 investors for this company. to use credits for reveals, or explore the API.

About

Mosanna Therapeutics is a clinical-stage biotech company developing a novel pharmaceutical approach to treating obstructive sleep apnea (OSA), which affects an estimated 1 billion people globally. Its lead therapy, MOS118, is an easy-to-use nighttime nasal spray designed to restore the body's natural upper airway reflex during sleep — treating OSA as a neurological and muscular dysfunction rather than a purely mechanical problem. This positions MOS118 as a non-invasive alternative to CPAP and other mechanical treatments. The $80 million Series A was led by Pivotal bioVenture Partners and EQT Life Sciences, with co-leads Forbion, Broadview Ventures, and Norwest. MOS118 is currently in Phase 1 clinical trials, with the new funding advancing it through Phase 2. Mosanna has offices in Redwood City, California and Basel, Switzerland.

Funding History

Data from Indexed.vcUpdated
Series ASeries AJun 2025
$80.0M

2 more funding events

  • Seed20232 investors
  • Seed2022

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Backend ×2
  • Marketing & SEO ×2
  • DevOps ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mosanna Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/mosanna-therapeutics"><img src="https://indexed.vc/api/badge/company/mosanna-therapeutics" alt="Mosanna Therapeutics on Indexed.vc" width="260" height="76" /></a>